QuidelOrtho Expands in Infectious Disease Testing With New FDA Nod [Yahoo! Finance]
QuidelOrtho Corporation (QDEL)
Last quidelortho corporation earnings: 2/12 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.quidel.com
Company Research
Source: Yahoo! Finance
specific to Treponema pallidum (TP) in human serum and plasma using automated VITROS 3600, 5600, and XT 7600 systems. The diagnosis of syphilis infection may be aided by the presence of antibodies to TP-specific antigens, non-treponemal laboratory testing, and clinical symptoms. Screening for blood and tissue donors is not intended to be performed with the VITROS syphilis assay. The VITROS syphilis assay is now accessible everywhere QuidelOrtho products are sold, including the United States. This important assay not only improves laboratory efficiency by allowing labs to follow the CDC's reverse testing algorithm for syphilis screening, but it also reduces costs by providing earlier disease detection, thereby reducing the need to refer tests to outside labs. QuidelOrtho's diagnostic testing solutions include the Sofia and Sofia 2 Analyzers, QuickVue, and InflammaDry and AdenoPlus products. In April 2024, QuidelOrtho announced the addition of the ARK Fentanyl II Assay to its U.
Show less
Read more
Impact Snapshot
Event Time:
QDEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QDEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QDEL alerts
High impacting QuidelOrtho Corporation news events
Weekly update
A roundup of the hottest topics
QDEL
News
- QuidelOrtho Co. (NASDAQ: QDEL) had its "market perform" rating re-affirmed by analysts at William Blair.MarketBeat
- QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle GroupBusiness Wire
- QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle GroupBusiness Wire
- In Vitro Diagnostics (IVD) Market to Reach USD 126.6 Billion by 2032, at 4.8% CAGR, Driven by Rising Prevalence of Chronic Diseases and Advances in Diagnostic Technologies – S&S Insider [Yahoo! Finance]Yahoo! Finance
- Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law FirmPR Newswire
QDEL
Earnings
- 11/7/24 - Beat
QDEL
Sec Filings
- 11/21/24 - Form SC
- 11/21/24 - Form 4
- 11/21/24 - Form 8-K
- QDEL's page on the SEC website